Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vera Therapeutics (NASDAQ:VERA)

Core Viewpoint - Vera Therapeutics, Inc. has granted inducement awards to six new employees, consisting of stock options and restricted stock units (RSUs), as part of its 2024 Inducement Plan [1][2]. Group 1: Inducement Awards - The Compensation Committee approved the grant of non-qualified stock options to purchase 46,000 shares of Class A common stock and RSUs for 25,875 shares of Class A common stock [1]. - The stock options have an exercise price of $39.30, which is the closing trading price on March 3, 2026 [2]. - The vesting schedule for stock options includes 25% vesting on the first anniversary, with the remaining shares vesting monthly over the next 36 months, contingent on continued service [2]. Group 2: Vesting Conditions - RSUs will also vest over four years, with 25% vesting on each anniversary of either February 20 or May 20, 2026, depending on the new employee's start date [2]. - Both stock options and RSUs are subject to the terms of the Inducement Plan and applicable award agreements [2].